Furthermore, FT3 and FT3/FT4 suppressed the negative association between BMI and serum osteocalcin levels, suggesting that obesity-related high FT3 levels may alleviate the decline in serum osteocalcin levels. This evidence concerns the gene BGLAP and obesity due to melanocortin 4 receptor deficiency.